NIV in the Treatment of Acute Respiratory Failure: Controversial Indications

A case of pneumonia that requires ventilation, whether invasively or non invasively, is always a serious event associated with a high mortality rate, particularly in the elderly, even though it is often considered by the media as an infection that is “easy” to resolve. Why is this a controversial in...

Descripción completa

Detalles Bibliográficos
Autores principales: Nava, Stefano, Fanfulla, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121719/
http://dx.doi.org/10.1007/978-88-470-5526-1_13
_version_ 1783515264141230080
author Nava, Stefano
Fanfulla, Francesco
author_facet Nava, Stefano
Fanfulla, Francesco
author_sort Nava, Stefano
collection PubMed
description A case of pneumonia that requires ventilation, whether invasively or non invasively, is always a serious event associated with a high mortality rate, particularly in the elderly, even though it is often considered by the media as an infection that is “easy” to resolve. Why is this a controversial indication for NIV? Because there are observational studies that are absolutely against the use of NIV and a couple of randomized controlled trial in favor, in theory, but not necessarily in all cases of pneumonia or in all patients.
format Online
Article
Text
id pubmed-7121719
institution National Center for Biotechnology Information
language English
publishDate 2013
record_format MEDLINE/PubMed
spelling pubmed-71217192020-04-06 NIV in the Treatment of Acute Respiratory Failure: Controversial Indications Nava, Stefano Fanfulla, Francesco Non Invasive Artificial Ventilation Article A case of pneumonia that requires ventilation, whether invasively or non invasively, is always a serious event associated with a high mortality rate, particularly in the elderly, even though it is often considered by the media as an infection that is “easy” to resolve. Why is this a controversial indication for NIV? Because there are observational studies that are absolutely against the use of NIV and a couple of randomized controlled trial in favor, in theory, but not necessarily in all cases of pneumonia or in all patients. 2013-11-23 /pmc/articles/PMC7121719/ http://dx.doi.org/10.1007/978-88-470-5526-1_13 Text en © Springer-Verlag Italia 2014 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Nava, Stefano
Fanfulla, Francesco
NIV in the Treatment of Acute Respiratory Failure: Controversial Indications
title NIV in the Treatment of Acute Respiratory Failure: Controversial Indications
title_full NIV in the Treatment of Acute Respiratory Failure: Controversial Indications
title_fullStr NIV in the Treatment of Acute Respiratory Failure: Controversial Indications
title_full_unstemmed NIV in the Treatment of Acute Respiratory Failure: Controversial Indications
title_short NIV in the Treatment of Acute Respiratory Failure: Controversial Indications
title_sort niv in the treatment of acute respiratory failure: controversial indications
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121719/
http://dx.doi.org/10.1007/978-88-470-5526-1_13
work_keys_str_mv AT navastefano nivinthetreatmentofacuterespiratoryfailurecontroversialindications
AT fanfullafrancesco nivinthetreatmentofacuterespiratoryfailurecontroversialindications

Ejemplares similares